UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
Date of Report (Date of earliest event reported): |
February 22, 2017 |
|
|
Commission File Number |
000-31380 |
|
|
APPLIED MINERALS, INC. | ||||||
|
(Exact name of registrant as specified in its charter) |
|
Delaware |
|
82-0096527 | ||||
|
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) | ||||
|
|
|
| ||||
|
|
|
| ||||
|
110 Greene Street, Suite 1101, New York, NY |
|
10012 | ||||
|
(Address of principal executive offices) |
|
(Zip Code) | ||||
|
|
(212) 226-4265 |
| ||||
|
|
(Issuer’s Telephone Number, Including Area Code) |
| ||||
|
| ||||||
|
(Former name or former address, if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
□ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230-425) |
|
|
|
|
□ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12) |
|
|
|
|
□ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
□ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Bradley Tirpak resigned as a director on February 22, 2017
SIGNATURES
In accordance with the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
APPLIED MINERALS, INC. |
|
|
|
|
|
|
|
Dated: |
|
February 23, 2017 |
|
/s/ ANDRE ZEITOUN |
|
|
|
|
|
By: Andre Zeitoun |
|
|
|
|
|
President and Chief Executive Officer |